Colorectal cancers have the highest number of Wnt signaling mutations, and nearly 85% of colorectal cancers have a loss-of-function mutation in APC, while 50% of tumors without an APC mutation have an activating mutation in β-catenin. This evidence concerns the gene APC and colorectal cancer.